Latest Epoxides Stories
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Feb.
US Submission Designed to Support Conversion From Accelerated to Full FDA Approval and Expansion of Current Approved Indication THOUSAND OAKS, Calif.
Maximum tolerated dose (MTD) identified and expansion cohort open to enrollment; Minimal Response (MR) or better has been observed in 25% of 8 patients treated to date at the MTD or higher
Data From Pivotal Trial Published in the New England Journal of Medicine and Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition THOUSAND OAKS, Calif.
Topical research study “Epichlorohydrin (ECH): 2014 World Market Outlook and Forecast up to 2018” elaborated by Merchant Research & Consulting Ltd is now available at mcgroup.co.uk.
Presentations Including Pivotal Data on Kyprolis® and Blinatumomab, a BiTE® Immunotherapy, Demonstrate Company's Continued Commitment to Developing Treatments for Difficult-to-Treat Blood Cancers THOUSAND
- Final results from binimetinib Phase 2 in NRAS melanoma confirmed prior Progression Free Survival result and demonstrated encouraging Overall Survival- BOULDER, Colo., Nov.
LifeScienceIndustryResearch.com adds “Spiriva (Asthma) – Forecast and Market Analysis to 2023” to its store.
DALLAS, September 13, 2014 /PRNewswire/ -- RnRMarketResearch.com offers epoxy resin industry research reports with 2009-2019 and 2013-2016 forecasts on global and Chinese